Related Experiment Video
Updated: May 9, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor
Elena Odintsova1, Guillaume van Niel2, Hélène Conjeaud3
1From the School of Cancer Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom,.
Abstract:
Ligand-induced ubiquitylation of EGF receptor (EGFR) is an important regulatory mechanism that controls endocytic trafficking of the receptor and its signaling potential. Here we report that tetraspanin CD82/KAI1 specifically suppresses ubiquitylation of EGFR after stimulation with heparin-binding EGF or amphiregulin and alters the rate of recruitment of the activated receptor to EEA1-positive endosomes. The suppressive effect of CD82 is dependent on the heparin-binding domain of the ligand. Deletion of the C-terminal cytoplasmic domain of CD82 (CD82ΔC mutant) inhibits endocytic trafficking of the tetraspanin and compromises its activity toward heparin-binding EGF-activated EGFR. Reduced ubiquitylation of EGFR is accompanied by PKC-dependent increase in serine phosphorylation of c-Cbl in cells expressing elevated levels of CD82. Furthermore, phosphorylation of threonine 654 (PKC phosphorylation site) in the juxtamembrane domain of the receptor is considerably increased in CD82-expressing cells. These results describe previously unsuspected links between tetraspanin proteins and ubiquitylation of their molecular partners (e.g., EGFR). Our data identify CD82 as a new regulator of c-Cbl, which discriminatively controls the activity of this E3 ubiquitin ligase toward heparin-binding ligand-EGFR pairs. Taken together, these observations provide an important new insight into the modulatory role of CD82 in endocytic trafficking of EGF receptor.
Insights
Tetraspanin CD82 suppresses the ubiquitylation of the epidermal growth factor receptor (EGFR) upon stimulation with specific ligands. This regulation impacts EGFR trafficking and signaling, revealing a new role for CD82 in controlling EGFR ubiquitylation.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Epidermal growth factor receptor (EGFR) ubiquitylation is crucial for regulating its endocytic trafficking and signaling.
- Tetraspanins are membrane proteins involved in various cellular processes, including receptor trafficking and signaling modulation.
Purpose of the Study:
- To investigate the role of tetraspanin CD82 in the ubiquitylation and trafficking of EGFR.
- To elucidate the molecular mechanisms by which CD82 influences EGFR regulation.
Main Methods:
- Cell-based assays using CD82 expression and CD82 mutants.
- Analysis of EGFR ubiquitylation, endocytosis, and phosphorylation.
- Western blotting and immunofluorescence microscopy.
Main Results:
- CD82 specifically suppresses EGFR ubiquitylation induced by heparin-binding EGF and amphiregulin.
- CD82's suppressive effect is ligand-dependent and requires its C-terminal cytoplasmic domain.
- CD82 influences EGFR recruitment to EEA1-positive endosomes and increases EGFR phosphorylation at Thr654.
- CD82 upregulates PKC-dependent serine phosphorylation of c-Cbl.
Conclusions:
- CD82 acts as a novel regulator of EGFR ubiquitylation and endocytic trafficking.
- CD82 discriminatively controls the E3 ubiquitin ligase activity of c-Cbl towards specific EGFR-ligand complexes.
- These findings highlight a previously unrecognized link between tetraspanins and the ubiquitylation machinery.
Related Concept Videos
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases

